South Korea reviews AstraZeneca vaccine for elderly under rollout plan
SEOUL (Reuters) - South Korea will review the use of AstraZenecaâ€™s COVID-19 vaccine for the elderly because of limited efficacy data, the government said on Thursday, as it unveiled a plan to inoculate 10 million high-risk people by July.
